Breakthroughs in scientific research and a growing body of evidence show that an oral probiotic strain, Streptococcus salivarius K12, clinically demonstrates protection against bacterial infections of the respiratory tract caused by COVID-19 and other respiratory viruses making it a new weapon in the fight against infectious disease and COVID-19. As COVID-19 vaccines fail to block infection, do…